• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对称苯并咪唑基苯甲酰胺解旋酶抑制剂的作用机制和特异性。

Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.

机构信息

Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York 10595, USA.

出版信息

Biochemistry. 2010 Mar 9;49(9):1822-32. doi: 10.1021/bi901974a.

DOI:10.1021/bi901974a
PMID:20108979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832472/
Abstract

This study examines the effects of 1-N,4-N-bis[4-(1H-benzimidazol-2-yl)phenyl]benzene-1,4-dicarboxamide ((BIP)(2)B) on the NS3 helicase encoded by the hepatitis C virus (HCV). Molecular beacon-based helicase assays were used to show that (BIP)(2)B inhibits the ability of HCV helicase to separate a variety of RNA and DNA duplexes with half-maximal inhibitory concentrations ranging from 0.7 to 5 microM, depending on the nature of the substrate. In single turnover assays, (BIP)(2)B only inhibited unwinding reactions when it was preincubated with the helicase-nucleic acid complex. (BIP)(2)B quenched NS3 intrinsic protein fluorescence with an apparent dissociation constant of 5 microM, and in the presence of (BIP)(2)B, HCV helicase did not appear to interact with a fluorescent DNA oligonucleotide. In assays monitoring HCV helicase-catalyzed ATP hydrolysis, (BIP)(2)B only inhibited helicase-catalyzed ATP hydrolysis in the presence of intermediate concentrations of RNA, suggesting RNA and (BIP)(2)B compete for the same binding site. HCV helicases isolated from various HCV genotypes were similarly sensitive to (BIP)(2)B, with half-maximal inhibitory concentrations ranging from 0.7 to 2.4 microM. (BIP)(2)B also inhibited ATP hydrolysis catalyzed by related helicases from Dengue virus, Japanese encephalitis virus, and humans. (BIP)(2)B appeared to bind the HCV and human proteins with similar affinity (K(i) = 7 and 8 microM, respectively), but it bound the flavivirus proteins up to 270 times more tightly. Results are discussed in light of a molecular model of a (BIP)(2)B-HCV helicase complex, which is unable to bind nucleic acid, thus preventing the enzyme from separating double-stranded nucleic acid.

摘要

本研究考察了 1-N,4-N-双[4-(1H-苯并咪唑-2-基)苯基]苯-1,4-二羧酸酰胺((BIP)(2)B)对丙型肝炎病毒(HCV)编码的 NS3 解旋酶的影响。基于分子信标的解旋酶测定表明,(BIP)(2)B 抑制 HCV 解旋酶分离各种 RNA 和 DNA 双链的能力,其半抑制浓度范围为 0.7 至 5μM,取决于底物的性质。在单轮实验中,(BIP)(2)B 仅在与解旋酶-核酸复合物预孵育时才抑制解旋反应。(BIP)(2)B 猝灭 NS3 内在蛋白荧光的表观解离常数为 5μM,并且在(BIP)(2)B 的存在下,HCV 解旋酶似乎不与荧光 DNA 寡核苷酸相互作用。在监测 HCV 解旋酶催化的 ATP 水解的实验中,(BIP)(2)B 仅在存在中间浓度 RNA 的情况下抑制解旋酶催化的 ATP 水解,这表明 RNA 和(BIP)(2)B 竞争相同的结合位点。从各种 HCV 基因型中分离的 HCV 解旋酶对(BIP)(2)B 同样敏感,其半抑制浓度范围为 0.7 至 2.4μM。(BIP)(2)B 还抑制登革热病毒、日本脑炎病毒和人类相关解旋酶催化的 ATP 水解。(BIP)(2)B 似乎以相似的亲和力结合 HCV 和人蛋白(K(i)分别为 7 和 8μM),但与黄病毒蛋白的结合亲和力高达 270 倍。结果讨论了一种(BIP)(2)B-HCV 解旋酶复合物的分子模型,该模型无法结合核酸,从而阻止酶分离双链核酸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/662c53ee2de5/nihms175888f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/8e98f13a678b/nihms175888f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/60a87047f85a/nihms175888f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/192280b57584/nihms175888f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/8fa442856e34/nihms175888f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/f86e0bcaeee5/nihms175888f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/fdca474c79c3/nihms175888f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/662c53ee2de5/nihms175888f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/8e98f13a678b/nihms175888f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/60a87047f85a/nihms175888f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/192280b57584/nihms175888f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/8fa442856e34/nihms175888f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/f86e0bcaeee5/nihms175888f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/fdca474c79c3/nihms175888f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66c/2832472/662c53ee2de5/nihms175888f7.jpg

相似文献

1
Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.对称苯并咪唑基苯甲酰胺解旋酶抑制剂的作用机制和特异性。
Biochemistry. 2010 Mar 9;49(9):1822-32. doi: 10.1021/bi901974a.
2
Structure and function of hepatitis C virus NS3 helicase.丙型肝炎病毒NS3解旋酶的结构与功能
Curr Top Microbiol Immunol. 2000;242:171-96. doi: 10.1007/978-3-642-59605-6_9.
3
Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.利用体外荧光共振能量转移实时监测 RNA 解旋酶活性。
Biochem Biophys Res Commun. 2010 Feb 26;393(1):131-6. doi: 10.1016/j.bbrc.2010.01.100. Epub 2010 Feb 1.
4
Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis.模拟 RNA 刺激丙型肝炎病毒 NS3 解旋酶催化 ATP 水解的堇菜衍生化合物。
J Biol Chem. 2013 Jul 5;288(27):19949-57. doi: 10.1074/jbc.M113.463166. Epub 2013 May 23.
5
In vitro selection of RNA aptamers against the HCV NS3 helicase domain.针对丙型肝炎病毒NS3解旋酶结构域的RNA适体的体外筛选。
Oligonucleotides. 2004;14(2):114-29. doi: 10.1089/1545457041526335.
6
Fuel specificity of the hepatitis C virus NS3 helicase.丙型肝炎病毒NS3解旋酶的底物特异性
J Mol Biol. 2009 May 15;388(4):851-64. doi: 10.1016/j.jmb.2009.03.059. Epub 2009 Mar 28.
7
The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.丙型肝炎病毒NS3蛋白:一种典型的RNA解旋酶及潜在药物靶点。
Curr Issues Mol Biol. 2007 Jan;9(1):1-20.
8
Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.使用2'-O-甲基RNA底物探究丙型肝炎病毒NS3的RNA刺激的ATP酶活性与解旋酶活性之间的关系。
Biochemistry. 2000 Mar 14;39(10):2619-25. doi: 10.1021/bi992127a.
9
Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.丙型肝炎病毒NS3 RNA解旋酶工程化富含精氨酸的亚结构域2的溶液结构与主链动力学
J Mol Biol. 2001 Nov 30;314(3):543-61. doi: 10.1006/jmbi.2001.5146.
10
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.鉴定羟基蒽醌为丙型肝炎病毒NS3解旋酶的新型抑制剂
Int J Mol Sci. 2015 Aug 7;16(8):18439-53. doi: 10.3390/ijms160818439.

引用本文的文献

1
Hepatitis C virus NS3 helicase contributes to (-) strand RNA synthesis.丙型肝炎病毒NS3解旋酶有助于负链RNA合成。
Nat Commun. 2025 Aug 27;16(1):8006. doi: 10.1038/s41467-025-63498-9.
2
Role of the Conserved DECH-Box Cysteine in Coupling Hepatitis C Virus Helicase-Catalyzed ATP Hydrolysis to RNA Unwinding.保守的 DECH-Box 半胱氨酸在 HCV 解旋酶催化的 ATP 水解与 RNA 解旋偶联中的作用。
Biochemistry. 2018 Oct 30;57(43):6247-6255. doi: 10.1021/acs.biochem.8b00796. Epub 2018 Oct 16.
3
Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families.对黄病毒科、冠状病毒科和小RNA病毒科单链RNA(+)病毒的RNA解旋酶的抑制作用
Int J Med Chem. 2011;2011:213135. doi: 10.1155/2011/213135. Epub 2010 Nov 14.
4
PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3.RK-33的聚乳酸-羟基乙酸共聚物纳米颗粒制剂:一种针对DDX3的RNA解旋酶抑制剂
Cancer Chemother Pharmacol. 2015 Oct;76(4):821-7. doi: 10.1007/s00280-015-2851-3. Epub 2015 Sep 2.
5
Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.靶向病毒解旋酶的苯并噻唑和吡咯烷酮类黄病毒抑制剂。
ACS Infect Dis. 2015 Mar 13;1(3):140-148. doi: 10.1021/id5000458.
6
Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.巴基斯坦丙型肝炎病毒NS3解旋酶的对接研究:一个可能的抗病毒药物靶点。
PLoS One. 2014 Sep 4;9(9):e106339. doi: 10.1371/journal.pone.0106339. eCollection 2014.
7
Hepatitis C virus NS3 inhibitors: current and future perspectives.丙型肝炎病毒 NS3 抑制剂:现状和未来展望。
Biomed Res Int. 2013;2013:467869. doi: 10.1155/2013/467869. Epub 2013 Oct 27.
8
Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP.金瑞酸调节丙型肝炎病毒 NS3 解旋酶对核酸和 ATP 的亲和力。
Biochemistry. 2013 Sep 10;52(36):6151-9. doi: 10.1021/bi4006495. Epub 2013 Aug 26.
9
Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.单纯疱疹病毒1型起源结合蛋白UL9与DNA的复合物作为新型抗病毒药物设计的平台。
J Biomol Struct Dyn. 2014;32(9):1456-73. doi: 10.1080/07391102.2013.820110. Epub 2013 Jul 24.
10
Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis.模拟 RNA 刺激丙型肝炎病毒 NS3 解旋酶催化 ATP 水解的堇菜衍生化合物。
J Biol Chem. 2013 Jul 5;288(27):19949-57. doi: 10.1074/jbc.M113.463166. Epub 2013 May 23.

本文引用的文献

1
Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.解旋酶抑制剂作为丙型肝炎的特异性靶向抗病毒疗法。
Future Virol. 2009 May 1;4(3):277-293. doi: 10.2217/fvl.09.7.
2
Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase.基于结构的三苯甲烷衍生物作为丙型肝炎病毒解旋酶抑制剂的发现
J Med Chem. 2009 May 14;52(9):2716-23. doi: 10.1021/jm8011905.
3
Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor.吖啶酮衍生物对丙型肝炎病毒亚基因组RNA复制的抑制作用:一种NS3解旋酶抑制剂的鉴定
J Med Chem. 2009 May 28;52(10):3354-65. doi: 10.1021/jm801608u.
4
Fuel specificity of the hepatitis C virus NS3 helicase.丙型肝炎病毒NS3解旋酶的底物特异性
J Mol Biol. 2009 May 15;388(4):851-64. doi: 10.1016/j.jmb.2009.03.059. Epub 2009 Mar 28.
5
Amidinoanthracyclines - a new group of potential anti-hepatitis C virus compounds.脒基蒽环类化合物——一类新型潜在抗丙型肝炎病毒化合物。
Biol Chem. 2009 Apr;390(4):351-60. doi: 10.1515/BC.2009.040.
6
The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase.丙型肝炎病毒的NS4A蛋白可促进NS3解旋酶进行RNA偶联的ATP水解。
J Virol. 2009 Apr;83(7):3268-75. doi: 10.1128/JVI.01849-08. Epub 2009 Jan 19.
7
NS3 helicase from the hepatitis C virus can function as a monomer or oligomer depending on enzyme and substrate concentrations.丙型肝炎病毒的NS3解旋酶可根据酶和底物浓度以单体或寡聚体的形式发挥作用。
J Biol Chem. 2009 Feb 20;284(8):4806-14. doi: 10.1074/jbc.M805540200. Epub 2008 Dec 16.
8
Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein.对黄病毒NS3蛋白解开RNA及ATP水解作用的见解。
EMBO J. 2008 Dec 3;27(23):3209-19. doi: 10.1038/emboj.2008.232. Epub 2008 Nov 13.
9
Monitoring helicase activity with molecular beacons.使用分子信标监测解旋酶活性。
Biotechniques. 2008 Oct;45(4):433-40, 442. doi: 10.2144/000112834.
10
Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.环扩展核苷类似物抑制RNA解旋酶和细胞内1型人类免疫缺陷病毒复制。
J Med Chem. 2008 Aug 28;51(16):5043-51. doi: 10.1021/jm800332m. Epub 2008 Aug 5.